Intech Biopharm (Taiwan) Insiders
| 6461 Stock | TWD 24.05 0.25 1.03% |
Intech Biopharm employs about 87 people. The company is managed by 2 executives with a total tenure of roughly 203 years, averaging almost 101.0 years of service per executive, having 43.5 employees per reported executive. Recap of Intech Biopharm's management performance can provide insight into the venture performance.
| Hugues Hung Insider Chief Officer |
| Weiwei Wu Insider G Mang |
Intech |
Intech Biopharm Management Team Effectiveness
The company has return on total asset (ROA) of (0.0739) % which means that it has lost $0.0739 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2765) %, meaning that it generated substantial loss on money invested by shareholders. Intech Biopharm's management efficiency ratios could be used to measure how well Intech Biopharm manages its routine affairs as well as how well it operates its assets and liabilities.Intech Biopharm Workforce Comparison
Intech Biopharm is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 174. Intech Biopharm totals roughly 87.0 in number of employees claiming about 50% of stocks in Biotechnology industry.
Intech Biopharm Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Intech Biopharm Price Series Summation is a cross summation of Intech Biopharm price series and its benchmark/peer.
Intech Biopharm Notable Stakeholders
An Intech Biopharm stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Intech Biopharm often face trade-offs trying to please all of them. Intech Biopharm's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Intech Biopharm's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hugues Hung | Chief Officer | Profile | |
| Weiwei Wu | G Mang | Profile |
About Intech Biopharm Management Performance
The success or failure of an entity such as Intech Biopharm often depends on how effective the management is. Intech Biopharm management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Intech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Intech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Intech Biopharm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Intech Biopharm. Check Intech Biopharm's Beneish M Score to see the likelihood of Intech Biopharm's management manipulating its earnings.
Intech Biopharm Workforce Analysis
Traditionally, organizations such as Intech Biopharm use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Intech Biopharm within its industry.Intech Biopharm Manpower Efficiency
Return on Intech Biopharm Manpower
| Revenue Per Employee | 447.1K | |
| Revenue Per Executive | 19.4M | |
| Net Loss Per Employee | 3.5M | |
| Net Loss Per Executive | 150.9M |
Additional Tools for Intech Stock Analysis
When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.